US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma by Dolph M, Tremblay G, Leong H

Connect to this object online.

Systematic review of health state utility values for acute myeloid leukemia by Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G

Connect to this object online.

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia by Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A

Connect to this object online.

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia by Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A

Connect to this object online.